Radiation Oncologist, Researcher, aspiring musician. all views my own
Joined December 2018
- Tweets 364
- Following 108
- Followers 411
- Likes 991
106 Photos and videos
7 Sep 2025
Epitaph on a Tyrant
Perfection, of a kind, was what he was after,……,
He knew human folly like the back of his hand…….
When he laughed, respectable senators burst with laughter,
And when he cried the little children died in the streets.
WH Auden (Apologies for the edits)
4
93
Michael MacManus retweeted
28 Mar 2025
Check this out! 😃
Clinical-research #fellowships in radiation oncology at @PeterMacCC 🇦🇺
Apply here ➡️ careers.petermac.org/job/MEL…
1
10
12
1,044
17 Feb 2025
Amazing data on KV minibeam treatments at Mayo Clinic presented at MMND-ITRO in Sydney. Fantastic local and abscopal responses in patients with highly resistant tumours! Encouraging for pursuing MRT research at Australian Synchrotron! @ausynchrotron @MayoClinic @PeterMacRadOnc
1
2
6
385
Michael MacManus retweeted
13 Feb 2025
Our congrats to Dr Fiona Hegi-Johnson, recipient of the George Hodgson Memorial Award.👏👏👏 Supported by the Peter MacCallum Cancer Foundation, the award funds a #radonc /radiobiol researcher @PeterMacCC to attend the Lorne Cancer Conference. @HegiFiona @PeterMacCC @PeterMacRes
3
1
12
910
4 Dec 2024
Hot off press in Lancet eBioMedicine, Final outcome data for TROG 99.03 with amazing translational data from Gandhi lab. authors.elsevier.com/sd/arti…
Rituximab and CD8 TCell status govern prognosis. Check out panel E! RT plus R a new standard of care? @PeterMacCC @PeterMacRadOnc
3
6
15
1,264
4 Dec 2024
First RCT to show advantage for RT plus systemic therapy vs RT alone in early stage low-grade follicular lymphoma. In addition to improved PFS also showed significant improvement in composite endpoint of risk of death or transformation to aggressive lymphoma.
1
112
9 Sep 2024
Terrific session on multimodality therapy in NSCLC at #wclc2024 Tantalising signals on potential role of induction chemoimmunotherapy before ChemoRT and even chemoimmunoRT before surgery. Thanks to discussant @gerryhanna for bringing clarity to a complex set of abstracts!
1
12
532
9 Sep 2024
Great presentation by @HegiFiona at the presidential session at #wclc2025 Compelling case for following best practice in lung cancer radiotherapy in clinical trials of radiation and systemic therapies. Timely staging and RT planning with PET, concurrent chemo and RT QA critical.
3
13
662
9 Sep 2024
Great discussion at #WCLC24 by Dr Chee Lee of really exciting early phase data from studies of 2 new TKIs with activity in HER2 mutant NSCLC. High response rates and acceptable toxicity.
1
7
342
Michael MacManus retweeted
6 Sep 2024
In this new article from @MP_MacManus, Dose-response relationships between radiation exposure, bone marrow function as measured by 18F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer. Read here in the #RedJournal: tinyurl.com/mcmanusred
1
5
21
3,902
Michael MacManus retweeted
17 May 2024
Our phenomenal #radonc team!!
A superbly productive and energising day of aspirations and strategic planning @PeterMacRadOnc
#thefutureisbright 😎
@PeterMacCC @svporceddu
3
7
42
2,325
Michael MacManus retweeted
16 Nov 2023
My bet is we need smarter #RT...immunotherapy can only go so far if the #NSCLC #radonc is shutting down the immune system....time to think of new ways to skin this old cat...@MP_MacManus @gerryhanna @sueyom @TommyJohn00 @harr
14 Nov 2023
Press Release PACIFIC2: Ph III Trial Concurrent consolidation durva cCRT in stage III NSCLC
No PFS Benefit
?Suggests timing of IO in relation to RT matters
*PACIFIC 'picked the winners' of those who completed cCRT
*These trials include diff grps of pts astrazeneca.com/media-centre…
1
2
11
1,833
12 Oct 2023
Where in the world could you find such a beautiful and uncrowded tropical beach as Port Douglas?
6
217
Michael MacManus retweeted
12 Oct 2023
✨From our latest issue✨
📢Lung shielding blocks significantly reduced mean lung doses in patients undergoing total body irradiation for haematological malignancies
@petalonski @MP_MacManus @belinda_campbe et al
ow.ly/s8a850PSIW5
4
7
546
Michael MacManus retweeted
23 Jun 2023
Well done & thank you to Dr Peta Lonski who led this project.👏 Peta is a super talented member of our #radphys team @PeterMacRadOnc & a truly fabulous colleague. So thankful to work with you, @petalonski! ⭐️ #womenwhocurie @PeterMacCC @JMIRO_Journal @WomenInLymphoma @MP_MacManus
23 Jun 2023
#EarlyView: Lung doses in patients undergoing total body irradiation for haematological malignancies with/without lung shielding
👉🏼Lung shielding blocks significantly reduced mean lung doses
@PeterMacRadOnc @petalonski @MP_MacManus @belinda_campbe et al
ow.ly/XGYM50OUsCr
2
5
15
2,014
Michael MacManus retweeted
6 Oct 2023
Congrats to Dr Mary Xu for her excellent work! Favourable outcomes from active surveillance of asymptomatic RT-induced meningiomas in #childhoodcancer #survivors.
Free access to 19 Nov, thanks to @RadiotherapyOn1 🙏
authors.elsevier.com/c/1hrOs…
@PeterMacCC @RANZCRcollege @svporceddu
3
5
24
1,360
Michael MacManus retweeted
22 Sep 2023
In the TARGET-TP RCT of biomarker driven thromboprophylaxis for adults w/cancer, thromboembolism (8% vs 23%) & death (13% vs 26%) were substantially reduced among those w/high-risk biomarker profiles receiving enoxaparin vs no thromboprophylaxis. ja.ma/3roEewG
5
7
5,504